# Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain

> **NCT04530071** · PHASE1,PHASE2 · COMPLETED · sponsor: **CHABiotech CO., Ltd** · enrollment: 36 (actual)

## Conditions studied

- Chronic Low-back Pain
- Disc Degeneration

## Interventions

- **BIOLOGICAL:** CordSTEM-DD (0.7 x 10^7 cells)
- **BIOLOGICAL:** CordSTEM-DD (2.1 x 10^7 cells)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04530071
- **Lead sponsor:** CHABiotech CO., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-21
- **Primary completion:** 2023-04-17
- **Final completion:** 2023-04-17
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530071, "Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04530071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*